Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report) fell 5.3% during trading on Friday . The company traded as low as $0.18 and last traded at $0.18. 1,049 shares were traded during mid-day trading, a decline of 91% from the average session volume of 11,615 shares. The stock had previously closed at $0.19.
Alpha Tau Medical Price Performance
The firm has a 50 day simple moving average of $0.21 and a two-hundred day simple moving average of $0.23.
Alpha Tau Medical Company Profile
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.
Featured Articles
- Five stocks we like better than Alpha Tau Medical
- How to Invest in Small Cap Stocks
- Powering Your Portfolio: The Utility Sector’s Electrifying Surge
- The Basics of Support and Resistance
- Adobe Stock Builds Long-Term Value: Consider Buying on the Dip
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Albemarle Jumps as Lithium Stock Buying Frenzy Takes Off
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
